Navigation Links
New Clinical Trial Shows Ascenta Skin Supplement Improves Skin's Resistance to UV Exposure
Date:8/7/2014

Los Angeles, CA (PRWEB) August 07, 2014

Ascenta Health is proud to announce that their revolutionary dietary supplement Ascenta Skin has been clinically shown to increase the skin’s natural protection against ultraviolet (UV) radiation, the leading cause of skin damage and accelerated skin aging.

A recent clinical trial studied the effects of UV exposure on participants who took 4 capsules of Ascenta Skin daily over an eight week period. The results were astounding! Participants displayed on average an 83.8% increase in the UV exposure needed to produce the skin reddening effect that we consider sunburn after just eight weeks.

Sunburn, or reddening of the skin, is an acute skin response to excess UV exposure. Caused by both UVA and UVB, sunburn can be painful and damaging to your skin after you have overexposed yourself to the sun. The accumulated damage accelerates skin aging characterized by an increase in sagging, wrinkling, uneven tone and sun spots. Ascenta Skin’s unique formula of 6 naturally derived active ingredients including Omega-3’s and powerful antioxidants may be the next step in sun protection from the inside out.

“Because Ascenta Skin works from the inside out it produces dramatic results not typically seen with topical skin care products. By simply adding Ascenta Skin to their current skin care regimen consumers are experiencing firmer, smoother, younger looking skin,” says Marc St-Onge, Ascenta Health CEO and creator of Ascenta Skin. “The added benefit of enhanced UV protection proves that healthy, beautiful skin starts from within.”

Conducted at Consumer Product Testing Company, a laboratory at the forefront of sun protection testing, the research featured 28 participants that completed the trial. These participants had their minimal erythemal dose (MED), the smallest dose of UV radiation that produces skin redness, recorded at the beginning of the study. After taking Ascenta Skin daily, their results were measured at the four and eight week markers.

During the first 4 weeks, their MED increased by an average of 39.1% which seemed significant until the results were in for the full eight week period. The increase after 8 weeks of 83.8% in the UV exposure needed to produce reddened skin supports the theory that Ascenta Skin has a UV protective effect on your skin.

Ascenta Skin features 6 active ingredients including DHA, EPA, GLA, Zeaxanthin, Lutein and Vitamin D. In addition to reducing the effects of UV damage, Ascenta Skin is government approved in Canada to increase skin elasticity and firmness, hydration, and reduce roughness and redness including atopic dermatitis. Ascenta Skin’s “Beauty from Within” formula is a game changer in the skin care industry, all natural, science based, amazing skin care results and now UV protection. While Ascenta Skin significantly increases your skin’s resistance to UV it is not intended as a replacement for appropriate use of topical sunscreens.

Ascenta Skin is available to purchase on AscentaSkin.com and at renowned spas throughout Canada. Coming soon to cities across America, Ascenta Skin is currently available at Space.NK.Apothecary in New York and Los Angeles.

For more information on Ascenta Skin and to see remarkable before and after images, please visit http://www.AscentaSkin.com.

Read the full story at http://www.prweb.com/releases/AscentaSkin/08/prweb12078745.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. First targeted nanomedicine to enter human clinical studies
2. Clinical insight improves treatment with new lung cancer drug
3. Clinical news alert from the American Academy of Orthopaedic Surgeons
4. NYU Langone experts present research, clinical advances at neurosurgeons meeting
5. Kroenke honored for outstanding contributions in clinical research training
6. Awards celebrate clinical research that can improve health and alleviate suffering
7. Association for Psychological Science, SAGE launch Clinical Psychological Science
8. URMC clinical trial tests new regimen for hypertension
9. Analysis Finds Clinical Trials Often Small, of Poor Quality
10. Automated insulin dosage titration system demonstrates positive clinical study results
11. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
Breaking Medicine Technology: